Literature DB >> 11391229

beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus.

J H Nam1, J I Mun, S I Kim, S W Kang, K H Choi, K Park, C W Ahn, B S Cha, Y D Song, S K Lim, K R Kim, H C Lee, K B Huh.   

Abstract

BACKGROUND: Our study was undertaken to investigate the pathogenesis and possible risk factors for postrenal transplantation diabetes mellitus (PTDM).
METHODS: We recruited 114 patients with normal glucose tolerance (NGT) and performed both 75-g oral glucose tolerance tests (OGTT) and short insulin tolerance tests 1 week before and 9-12 months after transplantation.
RESULTS: The subjects were classified into three groups by World Health Organization criteria on the basis of OGTT after transplantation: (a) 36 (31.6%) subjects with normal glucose tolerance; (b) 51 (45.7%) subjects with impaired glucose tolerance (IGT); and (c) 27 (23.7%) subjects with postrenal transplantation diabetes mellitus. Dosages of steroid and cyclosporine were equivalent among the three groups. Before transplantation, the fasting and 2-hr plasma glucose and proinsulin/insulin (PI/I) ratios were significantly higher in the IGT and PTDM groups than in the NGT group, but the insulin sensitivity index (ISI) was not significantly different among the three groups. In addition, the area under the curve-insulin on OGTT was significantly lower in the PTDM group than in the NGT group. After transplantation, however, the ISI was increased in all groups. Furthermore, the ISI and PI/I ratios revealed significantly higher values in the PTDM group than in the NGT group after transplantation.
CONCLUSIONS: These results revealed that fasting and 2-hr plasma glucose levels, as well as the proinsulin/insulin ratio before transplantation, are both possible indicators of beta-cell dysfunction and may be predictors for the development of PTDM. Furthermore, beta-cell dysfunction, rather than insulin resistance, was proven to be the main factor for the pathogenesis of PTDM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391229     DOI: 10.1097/00007890-200105270-00011

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  35 in total

Review 1.  Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management.

Authors:  David Langsford; Karen Dwyer
Journal:  World J Diabetes       Date:  2015-08-25

2.  New-Onset Diabetes Mellitus After Transplantation in a Cynomolgus Macaque (Macaca fasicularis).

Authors:  Kristin A Matthews; Makoto Tonsho; Joren C Madsen
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

Review 3.  Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale.

Authors:  Moro O Salifu; Fasika Tedla; Serhat Aytug; Amir Hayat; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

Review 4.  Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment.

Authors:  Jessica L Hwang; Roy E Weiss
Journal:  Diabetes Metab Res Rev       Date:  2014-02       Impact factor: 4.876

5.  Genetics of new-onset diabetes after transplantation.

Authors:  Jennifer A McCaughan; Amy Jayne McKnight; Alexander P Maxwell
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

6.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

7.  Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation.

Authors:  J Hjelmesaeth; S Sagedal; A Hartmann; H Rollag; T Egeland; M Hagen; K P Nordal; T Jenssen
Journal:  Diabetologia       Date:  2004-08-27       Impact factor: 10.122

8.  New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT.

Authors:  Shoichi Iida; Hideki Ishida; Tadahiko Tokumoto; Kazuya Omoto; Hiroki Shirakawa; Tomokazu Shimizu; Hiroyuki Amano; Kiyoshi Setoguchi; Taiji Nozaki; Daisuke Toki; Daisuke Tokita; Kazunari Tanabe
Journal:  Int Urol Nephrol       Date:  2010-02-19       Impact factor: 2.370

Review 9.  Obesity and metabolic syndrome in kidney transplantation.

Authors:  Heather LaGuardia; Rubin Zhang
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

10.  Post-transplant diabetes mellitus.

Authors:  Marília B Gomes; Roberta A Cobas
Journal:  Diabetol Metab Syndr       Date:  2009-10-05       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.